The patent for GID would be huge and would spike the price very nicely. When I spoke with Mark Kay I specifically asked him about this patent and after hemming and hawing a bit he told me they needed to rework it and reapply. I imagine the initial attempt was too broad a claim. It sounded like a reapply was in the works.
I would be VERY HAPPY if this puppy could get to .10/.15 and I would think that is a realistic goal based on cashflow positive and ever increasing units in the marketplace with the reccuring revenue. $1 is more of a dream and will only be reached if they get a contract for OOB or GID in one of the big time financial or health institutions. That will take some time as there are many layers of bureaucracy to navigate.
My beliefs come from the fact that they are one of the first to market in a field that is going to be in the spotlight more and more in coming years. The corporate market is where it's at for SFOR as I don't see consumers making the effort to protect themselves unless forced to.
News 
Market Data 
Discover 
